Research and analysis: Evaluation of endpoint PCR (EPCR) as a diagnostic test technology for SARS-CoV-2

Posted on:

This is a technical report by the NIHR UK Biocentre Ltd, in partnership with Kings College Hospital NHS Foundation Trust and NHS Test & Trace Scientific Validation and Assurance Group.

It provides evidence verifying the performance of the UltraDx SARS-CoV-2 N1/N2/RP endpoint PCR assay (LGC, Biosearch Technologies).



Source link